ClinicalTrials.gov
ClinicalTrials.gov Menu

A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00145171
Recruitment Status : Completed
First Posted : September 5, 2005
Last Update Posted : September 5, 2005
Sponsor:
Information provided by:
Mylan Bertek Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : August 2002